Oral morphine effectiveness in Nigerian patients with advanced cancer

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 26, Issue 1, 2012, Pages 24-29

  Eyelade, Olayinka R ^a   Ajayi, Ikeoluwapo O ^a   Elumelu, Theresa N ^a   Soyannwo, Olaitan A ^a   Akinyemi, Oluranti A ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

cancer; effectiveness; morphine; Nigeria; oral; pain

Indexed keywords

DIHYDROCODEINE; MORPHINE; PARACETAMOL; PENTAZOCINE; TRAMADOL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PAIN; DEMOGRAPHY; DESCRIPTIVE RESEARCH; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NIGERIA; OBSERVATIONAL STUDY; PAIN ASSESSMENT; PROSPECTIVE STUDY; QUESTIONNAIRE; UTERINE CERVIX CANCER;

ADMINISTRATION, ORAL; ADULT; AGED; ANALGESICS, OPIOID; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; NIGERIA; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES;

EID: 84859046704     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.3109/15360288.2011.650351     Document Type: Article

References (13)

1. Hillier ER. Oral morphine mixtures. BMJ. 1983;287:701-702.
2. Wiffen PJ, McQuay HJ. Oralmorphine for cancer pain [review]. Cochrane Database Syst Rev. 2007;(4):CD003868. Available at: http://www. thecochranelibrary.com. Accessed 21 July 2010.
3. De Conno F, Ripamonti C, Fafnoni E, et al. The MERITO Study: amulticentre trial of the analgesic effect and tolerability of normal-release oral morphine during 'titration phase' in patients with cancer pain. Palliat Med. 2008;22:214-221. (Pubitemid 351795925)
4. Merriman A, Harding R. Pain control inthe African context: the Ugandan introduction of affordable morphine to relieve suffering at the end of life. Philos Ethics Humanit Med. 2010;5-10.
5. Ripamonti CI, Campa T, Fagnoni E, Brunelli C, Luzzani M, Maltoni M, De Conno F; MERITO Study Group. Normalrelease oral morphine starting dose in cancer patients with pain. Clin J Pain. 2009;25:386-390.
6. Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP. Validity of four pain intensity rating scale. Pain. 2011;152:2399-2404.
7. Ajayi IO, Soyannwo OA, Adebamowo CA, Amanor-Boadu SD. Availability ofopioids for cancer pain in Nigeria. Nig J Surg. 2000;7:25-28.
8. Nuessle S, Gray A, Lambert G, et al. Pain control with morphine: evaluation of prescriptions for oral morphine for outpatients at King Faisal Specialist Hospital and Research Centre. Ann Saudi Med. 1996;16:371-376. (Pubitemid 26293606)
9. Adebamowo CA, Akarolo-Anthony. Cancer in Africa: opportunities for collaborative research and training. Afr J Med Med Sci. 2009;38(Suppl):5-13.
10. Umezulike AC, Tabansi SN, Ewunonu HA, Nwana EJ. Epidemiological characteristics of carcinoma of the cervix in the Federal Capital Territory of Nigeria. Niger J Clin Pract. 2007;10:143-146.
11. Bercovitch M, Waller A, Adunsky A. High dose morphine use in the Hospice setting and effect on life expectancy. Cancer. 1999;86:871-877.
12. Droney J, Ross J, Gretton S, Welsh K, Sato H, Riley J. Constipation in cancer patients on morphine. Support Care Cancer. 2008;16:453-459.
13. Mercadante S, Ferrera P, Casuccio A. Effectiveness and tolerability af amidotrizoate for the treatment of constipation resistant to laxatives in advanced cancer patients. J Pain Symptom Manage. 2011;41(2):421-425.